BRD4 and metastatic malignant neoplasm in the lymph nodes: Univariate analysis demonstrated that BRD4 expression (p < 0.001), lymph node metastasis (p < 0.001), lymphatic permeation (p < 0.001), and TNM stage (p < 0.001) were significant prognostic factors for poor survival (Table 3).